Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2007; 13(4): 579-584
Published online Jan 28, 2007. doi: 10.3748/wjg.v13.i4.579
Published online Jan 28, 2007. doi: 10.3748/wjg.v13.i4.579
Characteristics | |
Mean age, years, (range) | 36 (22–62) |
Sex | |
Male | 33 |
Female | 25 |
Race | |
Caucasian | 48 (100) |
ALT, IU/L (range) | 57 (9-263) |
HCV-RNA level, > 800.000 IU/mL | 23 (40) |
Mean level, IU/mL | 615.000 |
HCV genotype | |
1, 1a, 1b, 4 | 32 (55) |
2a, 2b, 3 | 24 (42) |
Not available | 2 (3) |
HCV genotype 1 and HCV-RNA > 800.000 IU/mL | 19 (33) |
Liver biopsy (available in 56 out of 58 patients) | |
No chronic hepatitis | 10 (17) |
Chronic hepatitis | 43 (74) |
Cirrhosis | 3 (5) |
Co-medication | |
Methadone | 4 (7) |
Codeine | 7 (12) |
- Citation: Witthoeft T, Fuchs M, Ludwig D. Recent IV-drug users with chronic hepatitis C can be efficiently treated with daily high dose induction therapy using consensus interferon: An open-label pilot study. World J Gastroenterol 2007; 13(4): 579-584
- URL: https://www.wjgnet.com/1007-9327/full/v13/i4/579.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i4.579